Biogen (Germany) Story

IDP Stock  EUR 180.00  3.00  1.64%   
Roughly 61% of Biogen's investor base is looking to short. The analysis of current outlook of investing in Biogen Inc suggests that many traders are alarmed regarding Biogen's prospects. Biogen's investor sentiment overview provides quick insight into current market opportunities from investing in Biogen Inc. The current market sentiment, together with Biogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Biogen Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Biogen stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Biogen daily returns and investor perception about the current price of Biogen Inc as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Biogen Inc.

Biogen Latest Timeline

Biogen Inc is currently traded for 180.00on Frankfurt Exchange of Germany. About 90.0% of the company shares are owned by institutional investors. The book value of Biogen was currently reported as 92.98. The company recorded earning per share (EPS) of 19.22. Biogen Inc had not issued any dividends in recent years.
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out Biogen Hype Analysis, Biogen Correlation and Biogen Performance.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.